Pharmacokinetics Services Market To Reach $1,762.4 Million By 2030

Pharmacokinetics Services Market Growth & Trends

The global pharmacokinetics services market size is expected to reach USD 1,762.4 million by 2030, registering a CAGR of 7.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising adoption of pharmacokinetic and toxicology studies for determination of several parameters such as no-observed-effect levels (NOEL), human equivalent doses (HED) levels, and pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel market growth. 

Thorough understanding of the pharmacokinetic profile of a potential drug candidate plays a major role in the success of a drug discovery program. In addition to this, regulatory bodies have played a major role in the progress of this market through establishing defined guidelines for conducting PK studies. There are a substantial number of CROs engaged in conducting PK studies in accordance with relevant EMEA, ICH, FDA, GCP, and other regulatory guidelines.

Growing concern for effective implementation of PK services in the drug development process is anticipated to drive investments in this sector. Several conferences and certification courses are being conducted across the world to increase the understanding of various paradigms associated with pharmacokinetics application in clinical and preclinical drug development.

 Request a free sample copy or view report summary: Pharmacokinetics Services Market Report

Pharmacokinetics Services Market Report Highlights

• Based on drug type, Small molecule dominated the market with a revenue share of 76.7% in 2022 and is expected to maintain its lead during the forecast period fueled by high service penetration and growing popularity of generics

• PK analysis for large molecules are expected to grow significantly during the forecast period, driven by presence of significant number of biologics and biosimilars in the clinical development phase

• Presence of a large number of biopharmaceutical and pharmaceutical manufacturing entities in U.S. has resulted in North America accounting for the largest share in 2022

• Asia Pacific is estimated to expand at the fastest CAGR of 9.2% over the forecast period thanks to constant economic growth in several countries, which has attracted significant attention from global CROs and resulted in business expansions

• Pharmaceutical Product Development, LLC; Charles River Laboratories International, Inc.; PAREXEL International Corporation; and Eurofins Scientific, Inc. are some of the key service providers

• These CROs are undertaking various initiatives in order to capitalize on new market avenues and enhance their share in the future market.

Pharmacokinetics Services Market Segmentation

Grand View Research has segmented the global pharmacokinetics services market on the basis of drug type, application, end-use, and region:

Pharmacokinetics Services Drug Type Outlook (Revenue, USD Million, 2018 - 2030)

• Small Molecules

• Large Molecules (Biopharmaceuticals)

Pharmacokinetics Services Application Outlook (Revenue, USD Million, 2018 - 2030)

• Small And Medium Enterprise

• Large Enterprise

Pharmacokinetics Services End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology & Pharmaceutical Companies

• Academic & Government Research Institutes

• Others

Pharmacokinetics Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Pharmacokinetics Services Market

• Evotec AG

• Certara, L.P.

• Pacific BioLabs

• GVK Biosciences Private Limited

• Shanghai Medicilon Inc.

• Pharmaceutical Product Development, LLC

• Charles River Laboratories International, Inc.

• PAREXEL International Corporation

• Eurofins Scientific, Inc

• Frontage Labs

• SGS SA

• LGC Limited

• Creative Bioarray